The document discusses the potential use of blockchain technology in the pharmaceutical cold chain, comparing it to traditional databases. While blockchain offers benefits like immutability, transparency, and enhanced security, its application in the pharma supply chain remains uncertain due to existing solutions like serialization and the relatively short shelf life of pharmaceuticals. The conclusion suggests that until blockchain proves its utility in other industries, traditional database solutions may be more effective for end-to-end monitoring in pharmaceuticals.